Poducer Logo
Daybreak

Daybreak

Business news is complex and overwhelming. It doesn’t have to be. Every day of the week, from Monday to Friday, Daybreak tells one business story that’s significant, simple and powerful. Hosted from The Ken’s newsroom by Snigdha Sharma and Rachel Varghese, Daybreak relies on years of original reporting and analysis by some of India’s most experienced and talented business journalists.

Episodes icon

10

Bookmyshow is betting big on India's concert boom. Selling tickets is the easy part

Bookmyshow is betting big on India's concert boom. Selling tickets is the easy part

<p>Guns N’ Roses got a taste of Bengaluru traffic on their way to their November 14 concert, arriving an hour late at NICE Grounds. The delay was a tiny reminder of how difficult it can be to put on a large live event in India. Venues are scarce, specialised equipment is hard to find, and permissions can be uncertain until the last minute.</p><p>And yet BookMyShow is investing in concert infrastructure to expand beyond ticketing into event production and promotion. The stakes are rising: private-equity giant KKR has reportedly invested $50 million in the company.</p><p>In this ep...

Ellipse
How Jio’s listing can put Mukesh Ambani’s “one indivisible Reliance” to the test

How Jio’s listing can put Mukesh Ambani’s “one indivisible Reliance” to the test

<p>Jio Platforms' IPO puts the spotlight on its close business relationship with Reliance Retail. The retailer is the sole distributor of Jio's prepaid connections, accounting for a substantial share of the telecom company's business. </p><p>This arrangement gives Jio access to a vast distribution network, but also creates a dependence that could become a risk. </p><p>As Jio enters the public markets and Reliance Retail prepares for its own listing, questions are emerging about related-party transactions, shareholder interests and the Ambani family's plan to keep Reliance together.</p><p>Tune in.</p><p>Daybreak is produced from...

Ellipse
The UPI shortcut to US stocks is all gas and no brakes

The UPI shortcut to US stocks is all gas and no brakes

<p>More and more Indians want a piece of American stocks, and the legal way in has become easier this year. But it’s still slow, and it doesn’t let you borrow to bet bigger. So a set of crypto platforms has stepped into that gap, letting traders bet on US stocks with heavy leverage, paid for through UPI. </p><p>Because the rupees never get converted into dollars, the money never officially leaves India, and that puts these platforms in a legal grey zone.</p><p>In this edition of The Ken's weekly Ka-Ching, read aloud by host Snigd...

Ellipse
India cut the tax on Scotch. Customs is now asking: what counts as Scotch?

India cut the tax on Scotch. Customs is now asking: what counts as Scotch?

<p>India drinks more whisky than any country on earth. Yet, pure Scotch makes up only about 3% of the whisky Indians drink. </p><p>And now, dozens of containers of it sit stuck at Indian ports. </p><p>Today, host Rachel Varghese unpacks a disagreement inside the Indian government over what counts as Scotch under the India-UK trade pact, and what it means for what's actually in your bottle. From the designer Diwali editions to the blends behind India's best-selling whiskies. </p><p>Tune in.</p><p>Listen to our last episode on India's alcohol boom here. </p><p>Daybreak...

Ellipse
Hospitals won’t pay for India’s medical inflation and insurers can’t

Hospitals won’t pay for India’s medical inflation and insurers can’t

<p>India’s insurance regulator, Irdai, got over 2 lakh comments on its plan to cut agent commissions. It is expected to revise the proposals by December. The plan responds to medical costs rising 12-14% a year. </p><p>Insurers spent up to Rs 118 for every Rs 100 of premiums in FY25. Meanwhile, hospitals have their own reasons to resist the standardisation of pricing. So the burden is shifting to agents and patients, through lower commissions and a proposed 10% co-pay. </p><p>But moving costs around doesn’t make healthcare cheaper. Who should pay for India’s rising medical bills?</p><p>Tune i...

Ellipse
Why global betting giants are paying Indian data scouts to see games before bettors

Why global betting giants are paying Indian data scouts to see games before bettors

<p>Gavin's job involves a seat in a stadium, two phones and only a few seconds to log everything that happens on the pitch. </p><p>He's a sports data scout in Guwahati. And the data he records is what ends up on going to global betting platforms, before the broadcast catches up.</p><p>Today, in Daybreak's video episode, The Ken's Sakshi Sadashiv and host Rachel Varghese explain who these scouts are, why a few seconds of delay is worth so much money, and how platforms keep people betting when the big tournaments season ends. </p><p>Tune in.<...

Ellipse
Engineering profits are slipping and L&T Tech is going all in on AI

Engineering profits are slipping and L&T Tech is going all in on AI

<p>L&T Technology Services is making a big bet on AI to reverse a slide in its profit margins. The engineering services company has sold its Smart World and Communications business at a loss of Rs 350 crore, shifting its focus towards AI-led engineering projects. </p><p>Meanwhile, AI agents are helping it automate software testing, process complex engineering data and cut project timelines. The shift is also changing how LTTS hires employees, structures teams and charges clients. </p><p>But with competitors making similar moves and outcome-based billing bringing new risks, can AI deliver the profits LTTS is counting on...

Ellipse
“Clinically proven” has sold for years on trust. FSSAI is finally asking what’s behind it

“Clinically proven” has sold for years on trust. FSSAI is finally asking what’s behind it

<p>Complan's pitch to Indian parents has long been simple: grow taller, faster. Last month, FSSAI asked its maker to show the studies behind "clinically proven 2x growth". </p><p>Nestle got a similar notice. </p><p>And so did many other brands, as the FSSAI swept the industry, hitting atta to infant formula. So, why is the regulator going after brands so aggressively, and why now?</p><p>Tune in. </p>

Ellipse
Complan says it makes kids grow 2X faster. FSSAI wants to see the proof

Complan says it makes kids grow 2X faster. FSSAI wants to see the proof

<p>Complan's pitch to Indian parents has long been simple. It helps kids grow taller, faster. Last month, FSSAI asked its maker to show the studies behind it's claim: "clinically proven 2x growth". </p><p>Nestle got a similar notice for two of its baby formulas. </p><p>So did several other brands, as the FSSAI swept the industry, hitting products like atta to infant formula. So, why is the regulator going after brands that have been around for so long, so aggressively, and why now?</p><p>Tune in.</p><p>This episode was edited by Arnav Prakash. </p><...

Ellipse
India's jewellery makers are IPO-ing away to pay for gold

India's jewellery makers are IPO-ing away to pay for gold

<p>Eight jewellery companies have listed on India’s main board this year. Many of them are the behind-the-scenes makers who supply to big brands like Malabar, Kalyan, and Senco. Investors have lapped them up. One issue was oversubscribed a hundred times. On paper, it’s easy to see why, because their profits are soaring. </p><p>But they have to pay for gold upfront and wait months for retailers to pay them. In the end, their bank credit is almost wiped out. </p><p>So most of what investors handed over is going into repaying loans and buying gold. In t...

Ellipse
Poducer Logo